What is the recommended dose of Oseltamivir (Tamiflu) for a patient with moderate impaired renal function (creatinine clearance (CrCl) of 47)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oseltamivir Dosing for CrCl 47 mL/min

For a patient with CrCl 47 mL/min, use the standard oseltamivir dose of 75 mg twice daily for treatment or 75 mg once daily for prophylaxis—no dose adjustment is required. 1, 2

Critical Threshold for Dose Adjustment

  • The key threshold for oseltamivir dose reduction is CrCl <30 mL/min, not 46-47 mL/min. 1, 3
  • Your patient with CrCl 47 mL/min falls well above this threshold and should receive full-dose therapy. 1, 2
  • Multiple guidelines and the FDA label consistently establish 30 mL/min as the cutoff, not higher values like 46 or 60 mL/min. 1, 3

Standard Dosing Regimen (CrCl ≥30 mL/min)

For Treatment:

  • 75 mg orally twice daily for 5 days 1, 2, 4
  • Must be initiated within 48 hours of symptom onset for maximum benefit 2, 4
  • Can be taken with or without food, though administration with meals reduces gastrointestinal side effects (nausea/vomiting occur in 10-15% of patients) 2, 4

For Prophylaxis:

  • 75 mg orally once daily for 10 days after exposure 1, 2, 4
  • Should be started within 48 hours of exposure to an infected individual 2

Pharmacokinetic Rationale

  • The FDA label demonstrates that oseltamivir carboxylate (the active metabolite) exposure is inversely proportional to declining renal function. 3
  • At CrCl 30-60 mL/min (which includes your patient at 47 mL/min), simulated median exposures with standard 75 mg twice-daily dosing achieve therapeutic trough concentrations (Cmin) of 180 ng/mL and AUC48 of 12,008 ng·h/mL—comparable to patients with normal renal function. 3
  • Renal clearance of oseltamivir carboxylate (18.8 L/h) exceeds glomerular filtration rate, indicating tubular secretion contributes to elimination, but this mechanism remains adequate at CrCl 47 mL/min. 3, 5

Common Pitfall to Avoid

  • Do not confuse the 30 mL/min threshold with higher cutoffs (such as 60 mL/min) that appear in some older literature or general renal dosing references. 1
  • The well-established guideline and FDA-approved threshold is specifically CrCl <30 mL/min for dose reduction. 1, 3
  • Some clinicians mistakenly reduce doses at CrCl 30-60 mL/min, which results in subtherapeutic concentrations and reduced efficacy, particularly problematic since early therapeutic concentrations are critical for influenza treatment. 6

When Dose Reduction IS Required (For Reference)

Only if CrCl drops to 10-30 mL/min:

  • Treatment: 75 mg once daily (not twice daily) for 5 days 7, 1, 3
  • Prophylaxis: 30 mg once daily OR 75 mg every other day for 10 days 7, 1, 3

For CrCl <10 mL/min or hemodialysis:

  • Treatment: 30 mg per hemodialysis cycle 1
  • Prophylaxis: 30 mg every alternate hemodialysis cycle 1

References

Guideline

Oseltamivir Dosing Guidelines for Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Oseltamivir Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Tamiflu Dosing Guidelines for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the dosing adjustment for Tamiflu (oseltamivir) in patients with impaired renal function?
What is the recommended dose of oseltamivir (Tamiflu) for a patient with moderate impaired renal function (GFR of 50)?
What are the dosing recommendations for Oseltamivir (Tamiflu) and Ondansetron for an elderly male adult with Chronic Kidney Disease (CKD) stage 3?
What is the recommended dose of Oseltamivir (Tamiflu) for a patient with severe renal impairment (CrCl - Creatinine Clearance of 28)?
What is the recommended dose of Tamiflu (oseltamivir) for adult prophylaxis?
What is the best course of action for an elderly patient in their late 80s with grade one diastolic dysfunction, Chronic Kidney Disease (CKD) stage 3b, and Alzheimer's disease, who is experiencing hypotension after starting losartan (Angiotensin II Receptor Antagonist) 25mg, in addition to their current regimen of amlodipine (Calcium Channel Blocker) 10mg?
What medications can cause ulcers in an adult patient with a history of significant obesity and comorbidities like diabetes, hypertension, or sleep apnea who has undergone gastric bypass surgery?
What is the best course of action for a patient with a history of diabetes and hypertension, presenting with impaired renal function (decreased GFR) and potential dehydration?
What is the best management approach for an elderly patient with chronic kidney disease (CKD) and diastolic dysfunction, currently taking amlodipine (5mg) and losartan (25mg), to control blood pressure while minimizing the risk of hypotension?
What is the appropriate methadone (opioid analgesic) dose adjustment for a 70-year-old patient with chronic pain, currently taking methadone 15 mg three times a day (TID), who presents with sedation and dehydration due to inadequate fluid intake?
What therapy is effective for a patient with no clear underlying cause, experiencing anxiety when trying to sleep, to achieve quality sleep?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.